RxDoctor Payments DataLook up a doctor →

Mark Richards, MD

Clinical Cardiac Electrophysiology · Pocatello, IDNPI 1568487726

Payments from drug & device makers

$400,027in general payments, 2019–2025

Across 790 payments — averaging $506.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$211K
  • Johnson & Johnson$65K
  • Biotronik Inc.$42K
  • Abbott$30K
  • Acutus Medical, Inc.$20K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$18K
  • plus $14K from 12 others

What the payments were for

  • Consulting fees$70,88436%
  • Speaking & faculty fees$86,84344%
  • Travel & lodging$19,27510%
  • Food & beverage$20,60210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical cardiac electrophysiology providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$180,505
Medicare patients
822
Services billed
1,941

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban168$209,977
XareltoRivaroxaban76$78,049
EntrestoSacubitril/Valsartan23$23,219
Metoprolol Succinate278$4,880
Flecainide Acetate109$4,127
Amiodarone Hcl84$2,762
SotalolSotalol Hcl56$1,406
Diltiazem 24hr Er (La)Diltiazem Hcl13$844
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$494
Digoxin17$477
Spironolactone37$454
Lisinopril27$391
Potassium Chloride12$325
Rosuvastatin Calcium13$320
Furosemide44$319

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$65,366$78,04976 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical cardiac electrophysiology providers in Idahoon file to place this against a meaningful peer group, so we don't.

Other clinical cardiac electrophysiology in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →